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The mechanism underlying the protein–protein interaction of hnRNP K and PRMT family proteins is
unclear. We examined and conﬁrmed the arginine methylation of hnRNP K protein by PRMT1, not
CARM1, via their direct binding. We also studied hnRNP K protein complexes containing CARM1, as
well as PRMT1, using co-immunoprecipitation analysis. PRMT family proteins might be involved in
the regulation of hnRNP K functions in nuclear receptor coactivator, transactivation, and p21 gene
and protein expressions. We believe these observations will help provide insights into the regulation
of hnRNP K protein functions via the recruitment of its associated proteins, including its arginine
methylation-modifying proteins.
Structured summary:
MINT-6803853: hnRPK, (uniprotkb:P61978) binds (MI:0407) to PRMT1 (uniprotkb:Q99873) by pull down
(MI:0096)
MINT-6803884: hnRPK, (uniprotkb:P61978) physically interacts (MI:0218) with CARM1 (uni-
protkb:Q86X55) by anti tag coimmunoprecipitation (MI:0007)
MINT-6803869: hnRPK, (uniprotkb:P61978) physically interacts (MI:0218) with PRMT1 (uni-
protkb:Q99873) by anti tag coimmunoprecipitation (MI:0007)
MINT-6803939: hnRPK, (uniprotkb:P61978) binds (MI:0407) to PRMT2 (uniprotkb:P55345) by pull down
(MI:0096)
MINT-6803929: hnRPK, (uniprotkb:P61978) binds (MI:0407) to RMT (uniprotkb:P38074) by pull down
(MI:0096)
MINT-6803896: hnRPK, (uniprotkb:P61978) binds (MI:0407) to PRMT3 (uniprotkb:O60678) by pull down
(MI:0096)
MINT-6803834: PRMT1 (uniprotkb:Q99873) methylates (MI:0213) hnRPK, (uniprotkb:P61978) by methyl-
transferase assay (MI:0515)
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Heterogeneous nuclear nucleoprotein K (hnRNP K) is a member
of the family of heterogeneous nuclear ribonucleoproteins and is
predominantly present in the nucleus, but shuttles between the nu-
cleus and the cytoplasm via its K nuclear shuttling (KNS) domain
[1–3]. The involvement of hnRNP K in these processes, including
chromatin remodeling and transcription, as well as mRNA splicing,
export, and translation, reﬂects its ability to interact with a range ofchemical Societies. Published by E
titute of Medical Sciences,
Section 6, MinChuan, Taipei
. Huang).molecular partners, including DNA, RNA, and proteins. The mecha-
nisms by which the hnRNP K protein alters gene transcription are
not yet understood because this protein can activate and repress
the transcription of reporter genes linked to a heterologous pro-
moter or RNA polymerase II in a context-dependent manner [3–5].
Jackson’s study demonstrated that hnRNP K protein is stabilized
following DNA damage through the inhibition of its HDM2-medi-
ated ubiquitin-dependent degradation, and also that it serves as
a transcriptional cofactor for p53 [6]. The work of Hu further sug-
gested that hnRNP protein is markedly regulated by arginine meth-
ylation in response to ultraviolet radiation and this modiﬁcation
enhances its afﬁnity with p53 and p53 transcriptional activity
[7]. Protein arginine methyltransferase 1 (PRMT1) is identiﬁed as
the only methyltransferase that methylates hnRNP K, at amino acidlsevier B.V. All rights reserved.
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Post-translational modiﬁcation of arginine methylation does not
inﬂuence the RNA-binding activity, the translation inhibitory func-
tion, or the cellular localization of hnRNP K protein [9]. However,
the methylation status of hnRNP K protein may alter its protein–
protein interaction afﬁnity, such as c-Src [9].
Our previous study demonstrated the regulatory mechanism in-
volved in hnRNP K-p53 functional interactions in non-stress condi-
tions [10]. The results of that study provided evidence to support
that direct protein–protein interaction may be important for the
arginine methylation of hnRNP K protein by PRMT family proteins.
However, the arginine methylation status of hnRNP K was not the
only determinant for its physiological functions in nuclear receptor
and p53 transcriptional activations. The data here provide possible
mechanisms of how the non-enzymatic activity of PRMT family
protein associates with hnRNP K protein and regulates hnRNP K
protein-involved transactivation functions.
2. Materials and methods
2.1. Plasmids
Expression vectors for pSG5.HA.PRMT1, pSG5.HA.CARM1,
pSG5.HA.Zac1, pSG5.HA.GRIP1, pSG5.HA.p53, pSG5.HA.hnRNP K,
pcDNA3.Flag.hnRNP K, pET3a-HCV Core, pcDNA.HCV Core1-115,
pSV.AR0 for the human AR, pHE0 for the human ERa, and
Gal4DBD.hnRNP K338–363 were created as described previously
[10–13]. Arginine to lysine mutant (hnRNP K 5RK) was generated
by site directed mutagenesis using wild-type pSG5HA.hnRNP K
as the template (Stratagene, USA). Expression vector for yeast pro-
tein-arginine methyltransferase, RMT1, was a gift from Dr. Stallcup
MR (University of Southern California, LA, USA) [14]. Reporter
genes MMTV-LUC, EREII-LUC, GK1, and p21-LUC and bacterial
expression vectors for GST-Zac1, GST-PRMT1, GST-CARM1, and
GST-hnRNP K were described previously [10–13,15].2.2. Protein–protein interaction assays
For GST pull-down assays, 35S-labeled proteins were pro-
duced with the TNT T7-coupled reticulocyte lysate system (Pro-
mega, USA), and GST fusion proteins were produced in
Escherichia coli BL21. Proteins were translated in the presence
of 35S-mentinion in vitro, incubated with immobilized GST
fusion proteins, eluted and analyzed by gel electrophoresis as
previously described [13].
2.3. In vitro methylation assay
Methyltransferases were prepared as recombinant GST fusion
proteins and eluted from glutathione-agarose beads (Sigma, USA)
with 20 mM glutathione. 3 lg of GST-hnRNP K protein were incu-
bated with 1 lg of GST-PRMT1 or GST-CARM1 in the presence of
6 lM S-adenosyl-[methyl-3H]methionine (14.7 Ci/mmol, PerkinEl-
mer Life Sciences) in reaction buffer (20 mM Tris–HCl, pH 8.0,
200 mMNaCl, and 0.4 mM EDTA) at 30 C for 2 h in 35 ll reactions.
SDS-loading buffer or radio-immune precipitation buffer was used
to stop the reaction. Labeled proteins were identiﬁed by SDS–PAGE
and autoﬂuorography for 12 h.
2.4. Cell culture and transient transfection assays
HeLa cells were grown in DMEM supplemented with 10% char-
coal treated fetal bovine serum. The cells in each 24-well plate
were transfected with jetPEI (PolyPlus-transfection, France)
according to the manufacturer’s protocol; total DNA was adjustedto 1.0 lg by addition of the empty vector. Luciferase assays were
performed with the Promega Luciferase Assay kit, and the mea-
surement is expressed numerically as relative light units (RLU).
Luciferase activities are shown as the mean and deviation from
the mean of two transfected sets.
2.5. RT-PCR analysis
Total RNA was extracted from growing HeLa cells, using a total
RNA reagent (Bioman, Taiwan, ROC) according to themanufacturer’s
instructions. One microgram of total RNA was subjected to reverse
transcriptase, using oligo-dT12-18 primer for 60 min at 42 C (Prome-
ga). RT-PCRwas performed in the linear range with primers speciﬁc
forp21,p53, andGAPDH. Primers for the ampliﬁcationof target genes
were as follows: p21 (+30/+145), upper, 50-ctgagccgcgactgtgatgcg-
30; lower, 50-ggtctgccgccgttttcgacc-30; p53 (+61/+350), upper, 50-gat-
gaagctcccagaatgccagag-30; lower, 50-gagttccaaggcctcattcagctc-30;
GAPDH (+39/+240), upper, 50-gacctcaactacatggtttacatgt-30; lower,
50-cacgttggcagtggggacacg-30. Thermocycling conditions were as fol-
lows: 1 cycle at 95 C for 5 min and 30 cycles at 95 C for 40 s, 62 C
for 40 s, and 70 C for 40 s. Ampliﬁcation productswere subjected to
1.2% agarose gel electrophoresis and stainedwith ethidium bromide.
2.6. Immunoblots analysis
Cell lysates were prepared in lysis buffer (100 mM Tris–HCl pH
8.0, 150 mM NaCl, 0.1% SDS, and 1% Triton 100) at 4 C and were
separated by SDS–PAGE, transferred onto a polyvinylidine diﬂuo-
ride membrane (Millipore, USA) and detected by using antibodies
against HA-tag (3F10, Roche, Germany) and p53, p21, and HuR
(DO-1, C19, and 3A2, Santa Cruz Biotechnology, USA).
2.7. Statistical analysis
Statistical signiﬁcance was determined by a two-tailed un-
paired Student’s t-test using SPSS version 14 analysis. P < 0.05
was considered statistically signiﬁcant.3. Results and discussions
3.1. The physical interactions of hnRNP K protein with its arginine
methylation-modifying enzyme, PRMT family proteins
The arginine modiﬁcation of hnRNP K protein by type I PRMTs
serves unique, non-overlapping functions [16]. Previous studies
have demonstrated the distinct substrate preference of PRMT fam-
ily protein involved in the arginine methyltransferase reaction. For
example, hnRNP K is the substrate for PRMT1, not CARM1 (coacti-
vator arginine methyltransferase 1), and the RNA-binding protein
HuR is the substrate for CARM1, not PRMT1 [15,16]. The substrate
selectivity of hnRNP K by PRMT1, not by CARM1, was reconﬁrmed
using the arginine methylation assay (Fig. 1A). Our glutathione-S
transferase (GST) fusion pull-down analysis suggested that the
intensity of direct binding ability of hnRNP K with PRMT1 or
CARM1 determined the substrate speciﬁcity in the arginine
methylation assay (Fig. 1B). Hence, hnRNP K might serve as the
substrate for other PRMT family proteins, such as PRMT2A,
PRMT2B, and PRMT3, due to the ﬁndings on GST pull-down assay
(Fig. 1C).
In contrast, our co-immunoprecipitation (CO-IP) data demon-
strated that hnRNP K was not only able to interact with PRMT1,
but also with CARM1, implying that hnRNP K might be the sub-
strate of CARM1 in vivo (Fig. 1D, speciﬁc bands labeled as asterisk).
The other non-speciﬁc bands of the IP experiment should be
relevant to immunoglobulins, such as IgG protein (Fig. 1D, labeled
Fig. 1. The binding ability of PRMT family protein is required for in vitro
methylation of hnRNP K protein. (A) Five micrograms GST-hnRNP K protein was
incubated with 2 lg GST-CARM1 (lane 1) or GST-PRMT1 (lane 2) in the in vitro
methylation assay. Reactions were resolved by SDS–PAGE gel electrophoresis and
subjected to autoﬂuorography. Lane 3 was the Coomassie staining of GST-hnRNP K
protein. (B and C) The proteins indicated at the left of each panel were translated
in vitro and incubated with indicated bead-bound GST fusion proteins; bound
proteins were eluted, separated by SDS–PAGE, and visualized by autoradiography.
The percentage of labeled protein bound, as determined by phosphorimager
analysis, is shown below each lane. For comparison, the left lane of each panel
shows the indicated percentage of the input protein used in the binding reaction.
(D) HeLa cells transfected with 5 lg indicated pcDNA.Flag.hnRNP K,
pSG5.HA.PRMT1, and/or pSG5.HA.CARM1 expression vectors. Cell extracts (5%
aliquots) were subjected to immunoprecipitation with anti-Flag, and were then
immunoblotted with anti-HA antibody. NS: non-speciﬁc band.
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arginine methylation modiﬁcation. The type I PRMT enzymes, ex-
cept CARM1, general recognize glycine- and arginine-rich motifs
containing substrates [16], suggesting that the hnRNP K binding
site of CARM1 is distinct from its catalytic active site.
3.2. The functional roles of hnRNP K protein with PRMT family proteins
on nuclear receptor coactivator transcriptional systems
The transcriptional roles of hnRNP K have been well studied and
reported elsewhere [4,17,18]. Whether or not the arginine methyl-
ation residues of hnRNP K were involved in its transcriptional func-
tions through PRMT family proteins, CARM1 and PRTM1, and
related proteins, we examined the functional roles of hnRNP K in
various nuclear receptor coactivators, including a zinc-ﬁnger
protein which regulates apoptosis and cell cycle 1 (Zac1), glucocor-
ticoid receptor-interacting protein 1 (GRIP1), CARM1, and PRMT1,
for their coactivator activities on estrogen receptor- (ER) and
androgen receptor (AR)-dependent transcriptional systems
(Fig. 2). In the ER transcriptional systems, wild-type hnRNP K acted
synergistically and signiﬁcantly with Zac1 (P = 0.001) and GRIP1
(P = 0.043), but not CARM1 or PRMT1, whereas mutant hnRNP K(5RK) only acted synergistically and signiﬁcantly with Zac1
(P = 0.002), not GRIP1 (P = 0.261) (Fig. 2A; compare histograms
1–5). The synergistic effect between Zac1 and GRIP1 was further
signiﬁcantly enhanced by the co-expression of wild-type and mu-
tant hnRNP K (P = 0.005 and 0.007, respectively) (Fig. 2A; compare
histograms 1–3, and 6). Wild-type and 5RK mutant hnRNP K pro-
teins further and signiﬁcantly enhanced Zac1/GRIP1 complex with
CARM1 (P = 0.0005 and 0.001, respectively) and PRMT1 (P = 0.016
and 0.001, respectively) (Fig. 2A; compare histograms 6–8). The
signiﬁcant differences in the ER coactivator role between wild-type
and 5RK mutant hnRNP K proteins were observed when hnRNP K
worked with GRIP1 (P = 0.043), Zac1/GRIP1/CARM1 complex
(P = 0.028), or Zac1/GRIP1/PRMT1 complex (P = 0.023).
In the AR transcriptional systems, the repression role of hnRNP
K was found in wild-type and mutant forms (Fig. 2B; compare
histogram 1) and there were few or no signiﬁcant effects on the
coactivator complex containing Zac1 (P = 0.189 and 0.225, respec-
tively), GRIP1 (P = 0.151 and 0.342, respectively), CARM1, or
PRMT1 (Fig. 2B; compare histograms 1–5). The synergistic between
Zac1 and GRIP1 seemingly was signiﬁcantly enhanced by CARM1
(P = 0.001), PRMT1 (P = 0.09), and wild-type and mutant hnRNP K
proteins (P = 0.057 and 0.064, respectively) (Fig. 2B; compare his-
tograms 6–8). The signiﬁcant repression roles of wild-type and
mutant hnRNP K proteins were observed in the Zac1/GRIP1/CARM1
coactivator complex (P = 0.002 and 0.047, respectively) (Fig. 2B;
compare histograms 6–8). In contrast to ER system, no signiﬁcant
difference in the AR coactivator role between wild-type and 5RK
mutant hnRNP K proteins was observed.
Hence, our ﬁndings suggested that the functional roles of
hnRNP K in the nuclear receptor coactivator systems depend on
the type of nuclear receptor and coactivator within the working
complexes.3.3. Physical and functional interactions between PRMTs and HCV Core
proteins on the transactivation activity of hnRNP K protein
Previous work from Lai’s laboratory has demonstrated that hep-
atitis C virus (HCV) Core protein physically and functionally inter-
acts with hnRNP K [11]. We further observed the PRMT1 effect on
the binding ability between hnRNP K and HCV Core protein. Our
data showed that PRMT1 might enhance the binding ability of
HCV Core protein and itself to hnRNP K when PRMT1 and HCV Core
proteins were co-expressed and pulled-down by GST-hnRNP fusion
protein (Fig. 3A). This suggests that a better conformation of HCV
Core protein and PRMT1 forms a tripartite complex with hnRNP
K for their physiological functions. Our laboratory previously dem-
onstrated that amino acids 338–363 of hnRNP K protein expresses
itself maximal transactivation activity, independent of nuclear
localization signal and nuclear export signal within the K nuclear
shuttling domain [2,10]. Hence, the physical and functional effects
of HCV Core protein and PRMT1 on the transactivation activity of
hnRNP K protein were examined using the Gal4 DNA-binding do-
main fused with the transactivation domain of hnRNP K, amino
acids 338–363, and luciferase reporter in the HeLa cell. HCV Core
protein and PRMT1 both had the ability to enhance the transactiva-
tion activity of hnRNP K and both proteins acted additively or
synergistically using this reporter system (Fig. 3B). The HCV
Core protein-binding domain of hnRNP K protein is located
within amino acids residues 250–392, overlapping with its novel
transactivation domain [11]. Hence, HCV Core protein might
directly enhance the transactivation activity of hnRNP K protein.
It remains to be investigated whether these functional interactions
are required for HCV Core protein to relieve the suppression effect
of hnRNP K protein on the activity of the human thymidine kinase
gene promoter [11].
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and protein expressions in non-stress conditions
Controversial observations have been reported about the effects
of HCV Core protein on p53 and p21 expressions because of the dif-
ferent subcellular localizations for its nascent or mature forms
[19–22]. Our previous study demonstrated that hnRNP K protein
might serve as a p53 coactivator in the non-stress condition [10].
In this study, our reporter analysis demonstrated that PRMT1 en-
hanced the coactivator function of hnRNP K protein on p21 gene
promoter activity (P = 0.001) (Fig. 4A; compare histograms 1–4).
HCV Core or its C-terminal truncated (HCV Core1–115) protein
might serve as a p53 coactivator, and HCV Core1–115 protein ex-Fig. 2. The functional roles of arginine methylation status of hnRNP K on nuclear recept
EREII-LUC reporter gene (0.15 lg) and pHE0 (0.004 lg) encoding hERa (A) or MMTV-LU
indicated pSG5.HA, pSG5.HA.Zac1, pSG5.HA.GRIP1, pSG5.HA.CARM1, pSG5.HA.PRMT1, a
transfected cell extracts were determined. The numbers above the bars indicate activity
Fig. 3. Physical and functional interactions of PRMT1 and HCV Core protein in the regu
performed followed by the same procedure shown in Figure 1B. HeLa cells were trans
together with 0.3 lg of pSG5.HA vector, pET3a-HCV Core or pcDNA.HCV Core1–115, in
luciferase activity in the transfected cell extracts was determined, and the ratio value wa
factors. The presented data (B) are the means of three experiments (mean ± S.D.; n = 3).pressed the more signiﬁcant enhancement than full-length HCV
Core on p21 promoter reporter (P = 0.000 for C-truncated and
0.021 for full-length) (Fig. 4A; compare histograms 5–8 and 9–
12, black columns). Either full-length or C-truncated HCV Core pro-
tein alone had no signiﬁcant effect on p21 promoter activity
(P = 0.193 and 0.071, respectively). PRMT1 only signiﬁcantly en-
hanced the coactivator function of HCV Core1–115 protein
(P = 0.000), not full-length HCV Core protein (P = 0.532), within
the hnRNP K/p53 complex (Fig. 4A; compare histograms 8 and
12, open columns).
We examined and quantiﬁed the enhancement effect of hnRNP
K, p53, HCV Core1–115, and PRMT1 on the p53 and p21 gene and
protein using RT-PCR and Western blot analysis (Fig. 4B and C).or coactivator transcriptional systems. HeLa cells were transiently transfected with
C reporter gene (0.15 lg), pSVAR0 (0.1 lg) encoding AR (B), along with 0.15 lg of
nd/or pSG5.HA.hnRNP K (wt; 5RK) expression vectors. Luciferase activities of the
relative to that of pSG5.HA vector without added factors.
lation of the transactivation activity of hnRNP K. (A) The GST pull-down assay was
fected with 0.2 lg of the GK1-LUC reporter plasmid, 0.2 lg of pM.hnRNP K338–363,
the 0.3 lg of pSG5.HA (closed columns) or pSG5.HA.PRMT1 (open columns). The
s estimated relative to that of cells transfected with the pM.hnRNP K338–363 without
Fig. 4. The effects on p21 gene and protein are regulated by the p53-hnRNP K-HCV Core protein complex. (A) HeLa cells were transfected with 0.2 lg of p21-LUC, 0.2 lg of
pSG5.HA.hnRNP K, and/or 5 ng of pSG5.HA.p53, together with 0.2 lg of pSG5.HA vector, pET3a-HCV Core or pcDNA.HCV Core1–115, in the 0.2 lg of pSG5.HA (closed columns)
or pSG5.HA.PRMT1 (open columns). The luciferase activity in the transfected cell extracts was determined and the fold induction of the activity was estimated relative to that
of HeLa cells transfected with the pSG5.HA vector alone. HeLa cells were transiently transfected with 0.2 lg of pSG5.HA.hnRNP K and/or 5 ng of pSG5.HA.p53 together with
0.2 lg of pcDNA vector or pcDNA.HCV Core1–115 and were analyzed by RT-PCR (B) and Western blot (C) analysis to monitor the levels of endogenous p53, p21 and GAPDH
genes and endogenous p53, p21 and HuR proteins. We observed a similar expression pattern in two independent experiments. Band intensities were evaluated with Alpha
DigiDoc RT version 4.1.0 (JH Assoicates, India) for RT-PCR data and ImageJ version 1.42a (NIH, USA) for Western blotting data. (D) HeLa cells were transfected with 0.2 lg of
p21-LUC, 0.2 lg of pSG5.HA.hnRNP K (wt or 5RK mutant), together with 0.2 lg of pSG5.HA vector, pET3a-HCV Core or pcDNA.HCV Core1–115, in the 0.2 lg of pSG5.HA (closed
columns), pSG5.HA.PRMT1 (open columns) or pSG5.HA.CARM1 (gray columns). The presented data (A and D) are the means of three experiments (mean ± S.D.; n = 3).
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plex of hnRNP K, p53, HCV Core1–115, and PRMT1 were evident in
the RT-PCR analysis (Fig. 4B; compare lanes 5–8 and 1–4). The
induction p21 proteins by this quaternary complex were compara-
bly different in our Western blot analysis (Fig. 4C; compare lanes
5–8 with 1–4), suggesting that the inconsistent changes between
p21 and p53 might be mediated through a p53-independent path-
way in HeLa cells [23]. On further examination, we found that the
arginine methylation status of hnRNP K had no signiﬁcant differ-
ence upon its coactivator function on p21 gene promoter activity,
whether HCV Core protein or PRMT family proteins co-expressed
or not (all P values were >0.05) (Fig. 4D). This response was incon-
sistent with the response of UV-induced arginine methylation of
hnRNP K on p53 functions, as shown in Hu’s study [7].Several lines of evidence support that these ﬁve mutated argi-
nine residues are the major methylating sites of hnRNP K by
PRMT1 [7,8,15]. Our ﬁndings also suggest that direct interaction
might be important for PRMT family proteins to methylating
hnRNP K. Furthermore, in in vivo conditions, CARM1 could func-
tion with hnRNP K on various nuclear receptor coactivators or
p53-dependent system. Hence, our ﬁndings demonstrate that
CARM1 can indirectly interact and work with hnRNP K in vivo con-
ditions and PRMT1 could still function with mutant hnRNP K (5RK),
even mutant hnRNP K (5RK) relatively weaker bound to PRMT1
than wild-type hnRNP K in the GST pull-down analysis (data not
shown). In summary, the indirect binding ability of PRMT proteins
and the arginine methylation status of hnRNP K protein are not
necessary for the coactivator functions of these working com-
286 J.Y.-H. Chan et al. / FEBS Letters 583 (2009) 281–286plexes, suggesting that other factors determine their functional
roles in some transcriptional systems.
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